Kardashian Barker discusses the brand’s latest hair growth and anti-shedding capsule launch, her current post-pregnancy hair ...

KOURTNEY Kardashian is facing backlash after being branded “shameless” over an ill-timed birthday post on Kris Jenner’s birthday. Reality star Kourtney, 45, came under fire for ...

Ads for Ozempic and other weight loss meds are everywhere. The weight loss drug biz is a $100 billion industry. I know a ...

The real-world retrospective study evaluated the impact of GIMOTI (metoclopramide nasal spray) in patients with diabetic gastroparesis (DGP) who were concurrently using GLP-1 receptor agonists.

For patients with opioid use disorder (OUD) and alcohol use disorder (AUD), prescriptions of glucose-dependent insulinotropic polypeptide (GIP) and/or glucagon-like peptide-1 receptor agonists (GLP-1 ...

One of the biggest sensations fueling the healthcare space right now is the medication class of glucagon-like peptide-1 (GLP-1) agonists. Even if you aren't familiar with the term "GLP-1," you've ...

A recent article highlights the critical importance of skeletal muscle mass in the context of medically induced weight loss, particularly with the widespread use of GLP-1 receptor agonists. These ...

Researchers from Mass General Brigham and collaborators found that use of GLP-1 drugs to treat obesity more than doubled from 2022 to 2023 while rates of surgery dropped by one quarter. Key ...

GLP-1 Receptor Agonist Market Size 2024 GLP-1 Receptor Agonist Market is expected to reach USD 55.70 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 12.1% from 2024 to 2031. BURLINGAME, ...

Eli Lilly’s performance is riding on the success of GLP-1 weight loss and Alzheimer’s treatments. It is especially true for its GLP-1 drugs, which have led to massive gains, with more to come.

That’s where GlucoBoost GLP-1 Booster comes into play. This innovative supplement has garnered attention for its natural approach to weight loss, appealing to those who prefer avoiding synthetic ...